Related Experiment Video
Updated: Jun 14, 2026

07:18
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
Clinico-pathologic patterns of extremity liposarcoma.
S U Eyesan1, D C Obalum, D O Onovo
1Department of Orthopaedics and Trauma Surgery, National Orthopaedic Hospital, Lagos.
The Nigerian Postgraduate Medical Journal
|March 30, 2010
Summary
Liposarcoma is the most frequent extremity soft tissue sarcoma in Lagos, Nigeria, with the myxoid subtype being most common. This study describes its clinico-pathological features in male patients.
Area of Science:
- Oncology
- Pathology
- Surgical Oncology
Background:
- Liposarcoma originates from primitive cells differentiating into adipose tissue.
- Extremity liposarcoma represents a significant subset of soft tissue sarcomas.
- Understanding its clinico-pathological pattern is crucial for effective management.
Purpose of the Study:
- To delineate the clinico-pathological characteristics of liposarcoma affecting the extremities.
- To analyze demographic, clinical, and histological features of extremity liposarcoma in Lagos, Nigeria.
- To provide insights into the presentation and initial management of these tumors.
Main Methods:
- A descriptive study was conducted on patients with histologically confirmed extremity liposarcoma.
- Data collected included patient demographics, lesion location, histological type, and clinical stage.
- Analysis focused on clinico-pathological patterns and initial treatment approaches.
Main Results:
- Liposarcoma constituted 27.3% of soft tissue sarcomas, exclusively in males (6/6).
- The myxoid subtype was most prevalent (50%), predominantly affecting the thigh (83.3%).
- All patients presented at stage T2bNoMo, with most undergoing limb salvage surgery and radiotherapy.
Conclusions:
- Liposarcoma is the leading extremity soft tissue sarcoma in the studied population.
- Myxoid liposarcoma is the most common histological subtype encountered.
- Challenges in follow-up limited the assessment of survival and recurrence rates.

